Company shares last traded at $68.53 significantly below the 50 day moving average which is $77.52 and quite a bit lower than the 200 day moving average of $78.45. The 50 day moving average was down by -11.59% whereas the 200 day average was down by -12.65%. (NYSE:CVS) shares saw light trading volume with 7,117K shares changing hands in the last trading session. Shares saw a steep decrease in trading volume of 26.87% under the normal average daily volume.
Investors are a little more bullish on shares of CVS Health Corporation of late if you evaluate the change in short interest. The stock had a fall in short interest of -4.49% between September 29, 2017 and October 13, 2017. Short interest decreased 1,006,159 over that timeframe. With short interest at 21,400,669 and short average daily volume at 6,700,671, days to cover is 3.0 and the percentage of shorted shares is 0.02% as of October 13.
These funds have shifted positions in (CVS). As of quarter end Goelzer Investment Management, Inc. had disposed of a total of 502 shares trimming its stake by 0.7%. The value in dollars increased from $6,037,000 to $6,061,000 a change of $24,000 quarter to quarter. As of the end of the quarter Baskin Financial Services Inc. had sold 1,475 shares trimming its holdings by 1.7%. The value of the company’s investment in CVS Health Corporation went from $7,033,000 to $6,988,000 decreasing 0.6% quarter over quarter.
Andra Ap-fonden augmented its stake by buying 11,100 shares an increase of 10.3%. Andra Ap-fonden controls 118,600 shares worth $9,645,000. The value of the position overall is up by 11.5%. Hemenway Trust Co LLC bolstered its investment by buying 2,351 shares an increase of 1.5% in the quarter. Hemenway Trust Co LLC currently owns 156,214 shares with a value of $12,703,000. The total value of its holdings increased 2.6%.
The company is trading unchanged by % since yesterday’s close of $68.53. Additionally CVS Health Corporation recently declared a dividend payable on Friday November 3rd, 2017. The dividend will be $0.500 per share for the quarter which comes to $2.00 on an annualized basis. This dividend amount will represent a yield of $2.90. The ex-dividend date is Monday October 23rd, 2017.
The P/E ratio is 13.65 and the market value is 69.67B. As of the latest earnings report the EPS was $5.02 and is estimated to be $5.88 for the current year with 1,016,564,000 shares outstanding. Next quarter’s EPS is forecasted at $1.91 with next year’s EPS anticipated to be $6.35.
CVS Health Corporation, launched on August 22, 1996, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Company delivers products and services by advising patients on their medications at its CVS Pharmacy locations; introducing programs for clients at CVS Caremark; delivering care to patients with complex conditions through CVS Specialty, and providing access to care at CVS MinuteClinic. As of December 31, 2016, the Company had more than 9,700 retail locations and more than 1,100 walk-in healthcare clinics..